Doran Sophie L F, Romano Andrea, Hanna George B
Department of Surgery and Cancer, Imperial College, London, United Kingdom.
J Breath Res. 2017 Dec 6;12(1):016007. doi: 10.1088/1752-7163/aa8a46.
The lack of standardisation of breath sampling is a major contributing factor to the poor repeatability of results and hence represents a barrier to the adoption of breath tests in clinical practice. On-line and bag breath sampling have advantages but do not suit multicentre clinical studies whereas storage and robust transport are essential for the conduct of wide-scale studies. Several devices have been developed to control sampling parameters and to concentrate volatile organic compounds (VOCs) onto thermal desorption (TD) tubes and subsequently transport those tubes for laboratory analysis. We conducted three experiments to investigate (i) the fraction of breath sampled (whole versus lower expiratory exhaled breath); (ii) breath sample volume (125, 250, 500 and 1000 ml); and (iii) breath sample flow rate (400, 200, 100 and 50 ml min). The target VOCs were acetone and potential volatile biomarkers for oesophago-gastric cancer belonging to the aldehyde, fatty acids and phenol chemical classes. We also examined the collection execution time and the impact of environmental contamination. The experiments showed that the use of exhaled breath-sampling devices requires the selection of optimum sampling parameters. The increase in sample volume has improved the levels of VOCs detected. However, the influence of the fraction of exhaled breath and the flow rate depends on the target VOCs measured. The concentration of potential volatile biomarkers for oesophago-gastric cancer was not significantly different between the whole and lower airway exhaled breath. While the recovery of phenols and acetone from TD tubes was lower when breath sampling was performed at a higher flow rate, other VOCs were not affected. A dedicated 'clean air supply' reduces the contamination from ambient air, but the breath collection device itself can be a source of contaminants. In clinical studies using VOCs to elicit potential biomarkers of gastro-oesophageal cancer, the optimum parameters are 500 mls sample volume of whole breath with a flow rate of 200 ml min.
呼气采样缺乏标准化是导致结果重复性差的一个主要因素,因此是呼气测试在临床实践中难以应用的一个障碍。在线和袋式呼气采样有其优点,但不适合多中心临床研究,而样本储存和可靠运输对于开展大规模研究至关重要。已经开发了几种设备来控制采样参数,并将挥发性有机化合物(VOCs)浓缩到热脱附(TD)管上,随后将这些管子运送到实验室进行分析。我们进行了三项实验,以研究:(i)采样的呼气部分(全呼气与下呼吸道呼出的呼气);(ii)呼气样本体积(125、250、500和1000毫升);以及(iii)呼气样本流速(400、200、100和50毫升/分钟)。目标VOCs是丙酮以及属于醛类、脂肪酸和酚类化学类别的食管癌潜在挥发性生物标志物。我们还研究了采集执行时间和环境污染的影响。实验表明,使用呼出气体采样设备需要选择最佳采样参数。样本体积的增加提高了检测到的VOCs水平。然而,呼出呼气部分和流速的影响取决于所测量的目标VOCs。食管癌潜在挥发性生物标志物在全呼吸道和下呼吸道呼出的呼气中的浓度没有显著差异。虽然在较高流速下进行呼气采样时,TD管中酚类和丙酮的回收率较低,但其他VOCs不受影响。专用的“清洁空气供应”可减少来自环境空气的污染,但呼气采集设备本身可能是污染物的来源。在使用VOCs来寻找食管癌潜在生物标志物的临床研究中,最佳参数是全呼气样本体积为500毫升,流速为200毫升/分钟。